Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 9 announcements

Share price
₹2,474.90
Market cap
₹1,02,225 Cr
Revenue (annual)
₹14,278 Cr
Net profit (annual)
₹1,913 Cr
P/E (TTM)
50.0×Sector 50.4×
Promoter holding
72.63%-0.03% QoQ
FII holding
9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:50 IST BSE
Other Announcement

Mankind Pharma Other Announcement

Mankind Pharma has been assigned an ESG rating of 68.21 ('Leader' category) by Niche99 ESG Ratings, based on publicly available data for FY 2025-26.